Amphastar Pharmaceuticals(AMPH) - 2025 Q3 - Quarterly Results

RANCHO CUCAMONGA, CA – November 6, 2025 – Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) ("Amphastar" or the "Company"), a biopharmaceutical company focused on developing, manufacturing, and marketing complex generic and proprietary injectable, inhalation, and intranasal products, today reported results for the three months ended September 30, 2025. "Amphastar delivered another strong quarter, led by double-digit growth from BAQSIMI®, which achieved a 14% increase in revenue compared to the same period last ...